Richard Close
Stock Analyst at Canaccord Genuity
(1.97)
# 2,787
Out of 4,814 analysts
132
Total ratings
33.64%
Success rate
-9.54%
Average return
Main Sectors:
Stocks Rated by Richard Close
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFST LifeStance Health Group | Initiates: Buy | $8 | $6.70 | +19.40% | 1 | Apr 3, 2025 | |
| TALK Talkspace | Initiates: Buy | $5 | $2.67 | +87.27% | 1 | Apr 3, 2025 | |
| PHR Phreesia | Maintains: Buy | $34 → $35 | $23.94 | +46.20% | 9 | Mar 13, 2025 | |
| CLOV Clover Health Investments | Maintains: Buy | $4.2 → $4.5 | $3.60 | +25.00% | 3 | Mar 3, 2025 | |
| PRVA Privia Health Group | Maintains: Buy | $29 → $30 | $23.68 | +26.69% | 8 | Feb 28, 2025 | |
| PGNY Progyny | Maintains: Hold | $17 → $23 | $21.44 | +7.28% | 6 | Feb 28, 2025 | |
| HSTM HealthStream | Maintains: Hold | $29 → $30 | $32.47 | -7.61% | 6 | Feb 26, 2025 | |
| AHCO AdaptHealth | Maintains: Buy | $13 → $14 | $7.82 | +79.03% | 7 | Feb 26, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $42 → $50 | $36.44 | +37.21% | 4 | Feb 24, 2025 | |
| DOCS Doximity | Maintains: Hold | $60 → $71 | $53.20 | +33.46% | 9 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $21 → $19 | $19.45 | -2.31% | 12 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $16 | $8.97 | +78.37% | 11 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $3.85 | +159.74% | 7 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $1.98 | +203.03% | 3 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $17 | $6.83 | +148.90% | 15 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $117 → $121 | $108.98 | +11.03% | 3 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $2.12 | +136.41% | 5 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $1,170 → $225 | $1.41 | +15,857.45% | 6 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $32.26 | -25.60% | 3 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $79 → $95 | $67.23 | +41.31% | 9 | Apr 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $19 → $18 | $28.99 | -38.77% | 4 | Dec 20, 2018 |
LifeStance Health Group
Apr 3, 2025
Initiates: Buy
Price Target: $8
Current: $6.70
Upside: +19.40%
Talkspace
Apr 3, 2025
Initiates: Buy
Price Target: $5
Current: $2.67
Upside: +87.27%
Phreesia
Mar 13, 2025
Maintains: Buy
Price Target: $34 → $35
Current: $23.94
Upside: +46.20%
Clover Health Investments
Mar 3, 2025
Maintains: Buy
Price Target: $4.2 → $4.5
Current: $3.60
Upside: +25.00%
Privia Health Group
Feb 28, 2025
Maintains: Buy
Price Target: $29 → $30
Current: $23.68
Upside: +26.69%
Progyny
Feb 28, 2025
Maintains: Hold
Price Target: $17 → $23
Current: $21.44
Upside: +7.28%
HealthStream
Feb 26, 2025
Maintains: Hold
Price Target: $29 → $30
Current: $32.47
Upside: -7.61%
AdaptHealth
Feb 26, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $7.82
Upside: +79.03%
Waystar Holding
Feb 24, 2025
Maintains: Buy
Price Target: $42 → $50
Current: $36.44
Upside: +37.21%
Doximity
Feb 7, 2025
Maintains: Hold
Price Target: $60 → $71
Current: $53.20
Upside: +33.46%
Feb 5, 2025
Maintains: Hold
Price Target: $21 → $19
Current: $19.45
Upside: -2.31%
Jan 23, 2025
Maintains: Buy
Price Target: $23 → $16
Current: $8.97
Upside: +78.37%
Jan 21, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $3.85
Upside: +159.74%
Aug 16, 2024
Maintains: Buy
Price Target: $8 → $6
Current: $1.98
Upside: +203.03%
Aug 1, 2024
Maintains: Buy
Price Target: $25 → $17
Current: $6.83
Upside: +148.90%
Jul 31, 2024
Maintains: Neutral
Price Target: $117 → $121
Current: $108.98
Upside: +11.03%
May 9, 2024
Maintains: Buy
Price Target: $9 → $5
Current: $2.12
Upside: +136.41%
Mar 9, 2022
Maintains: Hold
Price Target: $1,170 → $225
Current: $1.41
Upside: +15,857.45%
Aug 4, 2021
Maintains: Buy
Price Target: $22 → $24
Current: $32.26
Upside: -25.60%
Apr 22, 2021
Maintains: Hold
Price Target: $79 → $95
Current: $67.23
Upside: +41.31%
Dec 20, 2018
Downgrades: Hold
Price Target: $19 → $18
Current: $28.99
Upside: -38.77%